It may be possible to accurately modify gene transcription in vivo using CRISPR without cleaving DNA, according to recent research
A biotech firm based in Boulder, CO is providing free access to MAD7 a novel enzyme in the gene editing field.
CRISPR Therapeutics is pioneering a new class of medicines, to conduct the first company-sponsored clinical trial of a CRISPR gene-edited therapy.
An adapted CRISPR technique could be used to treat incurable diseases, such as diabetes and muscular dystrophy, by turning up the volume on selected genes.
The US military invests $100m in genetic extinction technologies, after fears rise over channeling gene drives towards bioweaponry.
Harvard’s CRISPR pioneer, Chad Cowan has signed on to handle the preclinical work for new drugs slated to join the pipeline at a well-financed Mustang Bio.
In this podcast, Doudna talks about the ethical implications of changing the human genome, the importance of curiosity-driven science, and other topics.
Workarounds show robust mechanisms in place to keep surviving despite mutations.
A team of scientists have developed new nano-mapping technology that could transform the way disease-causing genetic mutations are diagnosed and discovered.
Josiah Zayner, the scientist who left NASA to bring genetic engineering to consumers has modified his own genome with CRISPR (true DIY style).
Scientists have succeeded in developing a method to target a cell’s DNA or RNA, to shut down the production of a protein.